Back to news

Elevance Health Gains as Medicare Advantage Sentiment Improves Ahead of Open Enrollment

Investivoq PriceTracker

Elevance Health (ELV) is up 3.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be improving sentiment around Medicare Advantage insurers as 2027 plan details come into focus ahead of the October 15 open-enrollment period. Elevance also entered this period with recently reaffirmed 2026 earnings guidance, which may be helping investors view the stock as more stable after a volatile year for managed-care names.

Details:

  • Elevance disclosed in a September 8-K that it was reaffirming full-year 2026 adjusted earnings guidance of at least $27.00 per diluted share during investor meetings.
  • The company announced 2027 Medicare Advantage offerings on October 1, highlighting broader plan choice, simpler benefits, and support services aimed at senior members.
  • CMS recently said the Medicare Advantage and prescription drug market should remain stable in 2027, with average MA premiums projected to decline, which can support investor confidence in the space.
  • This could also be because investors are repositioning within managed care ahead of fresh Medicare star-rating and enrollment catalysts, even without a single company-specific event today.

    • Sources:

    Elevance Health Investor Relations, SEC, CMS

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $ELV Insider Trading Activity

    ELV Insider Trades

    $ELV insiders have traded $ELV stock on the open market 6 times in the past 6 months. Of those trades, 3 have been purchases and 3 have been sales.

    Here’s a breakdown of recent trading of $ELV stock by insiders over the last 6 months:

    • GAIL BOUDREAUX (President and CEO) has made 2 purchases buying 2,725 shares for an estimated $1,002,230 and 0 sales.
    • RONALD W PENCZEK (CAO & Controller) has made 0 purchases and 2 sales selling 1,900 shares for an estimated $765,958.
    • RAMIRO G PERU purchased 1,000 shares for an estimated $366,050
    • ROBERT L JR DIXON sold 151 shares for an estimated $60,667

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    Investivoq Alerts
    Receive ELV Data Alerts
    Get market-moving data, filings, and signals for ELV in real time.
    Sign Up

    $ELV Hedge Fund Activity

    We have seen 819 institutional investors add shares of $ELV stock to their portfolio, and 638 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • CITIGROUP INC added 1,858,013 shares (+777.9%) to their portfolio in Q2 2026, for an estimated $718,549,367
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,803,703 shares (+inf%) to their portfolio in Q2 2026, for an estimated $697,546,061
    • FMR LLC added 1,155,933 shares (+58.5%) to their portfolio in Q2 2026, for an estimated $447,033,969
    • JPMORGAN CHASE & CO added 997,214 shares (+inf%) to their portfolio in Q2 2026, for an estimated $385,652,570
    • WELLINGTON MANAGEMENT GROUP LLP added 984,976 shares (+12.0%) to their portfolio in Q2 2026, for an estimated $380,919,768
    • ACADIAN ASSET MANAGEMENT LLC added 940,869 shares (+444.9%) to their portfolio in Q2 2026, for an estimated $363,862,268
    • NORGES BANK added 940,270 shares (+31.1%) to their portfolio in Q2 2026, for an estimated $363,630,617

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $ELV Government Contracts

    We have seen $282,017,044 of award payments to $ELV over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    • PART A/PART B MEDICARE ADMINISTRATIVE CONTRACTOR (MAC) JURISDICTION K (JK): $105,358,280
    • J6 A/B MAC SERVICES: $102,424,186
    • NEXT GENERATION DESKTOP IGF::OT::IGF: $52,070,094
    • SPARC WILL BE THE MAJOR CONTRACT VEHICLE FOR CMS IT SYSTEMS AND SUPPORT HHS OPDIVS CAN ALSO MAKE USE OF SPA...: $11,890,083
    • INNOVATION PAYMENT CONTRACTOR (IPC) CONTRACT AWARD: $3,912,509

    To track government contracts to publicy traded companies, check out Investivoq's government contracts dashboard. You can access data on government contracts through the Investivoq API government contracts endpoint.

    $ELV Price Targets

    Multiple analysts have issued price targets for $ELV recently. We have seen 15 analysts offer price targets for $ELV in the last 6 months, with a median target of $450.0.

    Here are some recent targets:

    • Ben Hendrix from RBC Capital set a target price of $439.0 on 07/09/2026
    • Sarah James from Cantor Fitzgerald set a target price of $450.0 on 07/07/2026
    • Lance Wilkes from Bernstein set a target price of $482.0 on 07/02/2026
    • Lisa Gill from JP Morgan set a target price of $476.0 on 06/08/2026
    • Ann Hynes from Mizuho set a target price of $465.0 on 06/08/2026
    • Erin Wright from Morgan Stanley set a target price of $404.0 on 06/04/2026
    • Kevin Fischbeck from B of A Securities set a target price of $460.0 on 06/04/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.